Literature DB >> 30662821

Theragnostic potentials of core/shell mesoporous silica nanostructures.

Aswathy Ravindran Girija1, Sivakumar Balasubramanian2.   

Abstract

Theragnostics is considered as an emerging treatment strategy that integrates therapeutics and diagnostics thus allowing delivery of therapeutics and simultaneous monitoring of the progression of treatment. Among the different types of inorganic nanomaterials that are being used for nanomedicine, core shell mesoporous silica nanoparticles have emerged as promising multifunctional nanoplatform for theragnostic application. Research in the design of core/shell mesoporous silica nanoparticles is steadily diversifying owing to the various interesting properties of these nanomaterials that are advantageous for advanced biomedical applications. Core/shell mesoporous silica nanoparticles, have garnered substantial attention in recent years because of their exceptional properties including large surface area, low density, ease of functionalization, high loading capacity of drugs, control of the morphology, particle size, tunable hollow interior space and mesoporous shell and possibility of incorporating multifunctional interior core material. In the past decade researcher's demonstrated tremendous development in design of functionalized core/shell mesoporous silica nanoparticles with different inorganic functional nanomaterial incorporated into mesoporous nanosystem for simultaneous therapeutic and diagnostic (theragnostic) applications in cancer. In this review, we recapitulate the progress in commonly used synthetic strategies and theragnostic applications of core/shell mesoporous silica nanoparticles with special emphasis on therapeutic and diagnostic modalities. Finally, we discuss the challenges and some perspectives on the future research and development of theragnostic core/shell mesoporous silica nanoparticles.

Entities:  

Keywords:  Cancer; Core/shell; Diagnostic; Mesoporous silica nanoparticles; Multifunctional; Theragnostic; Therapeutic

Mesh:

Substances:

Year:  2019        PMID: 30662821      PMCID: PMC6328307          DOI: 10.7150/ntno.27877

Source DB:  PubMed          Journal:  Nanotheranostics        ISSN: 2206-7418


  156 in total

1.  A clearer vision for in vivo imaging.

Authors:  R Weissleder
Journal:  Nat Biotechnol       Date:  2001-04       Impact factor: 54.908

Review 2.  The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting.

Authors:  H Maeda
Journal:  Adv Enzyme Regul       Date:  2001

Review 3.  Biodegradable nanoparticles for drug and gene delivery to cells and tissue.

Authors:  Jayanth Panyam; Vinod Labhasetwar
Journal:  Adv Drug Deliv Rev       Date:  2003-02-24       Impact factor: 15.470

Review 4.  Molecular imaging of cancer with positron emission tomography.

Authors:  Sanjiv Sam Gambhir
Journal:  Nat Rev Cancer       Date:  2002-09       Impact factor: 60.716

Review 5.  Causes and consequences of tumour acidity and implications for treatment.

Authors:  M Stubbs; P M McSheehy; J R Griffiths; C L Bashford
Journal:  Mol Med Today       Date:  2000-01

6.  Positron emission tomography provides molecular imaging of biological processes.

Authors:  M E Phelps
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

Review 7.  Cationic polymer based gene delivery systems.

Authors:  S C De Smedt; J Demeester; W E Hennink
Journal:  Pharm Res       Date:  2000-02       Impact factor: 4.200

8.  Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance.

Authors:  L R Hirsch; R J Stafford; J A Bankson; S R Sershen; B Rivera; R E Price; J D Hazle; N J Halas; J L West
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

9.  Taxol sensitizes human astrocytoma cells to radiation.

Authors:  R B Tishler; C R Geard; E J Hall; P B Schiff
Journal:  Cancer Res       Date:  1992-06-15       Impact factor: 12.701

10.  Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica.

Authors:  Nawal Kishor Mal; Masahiro Fujiwara; Yuko Tanaka
Journal:  Nature       Date:  2003-01-23       Impact factor: 49.962

View more
  2 in total

1.  Recent advances in porous nanostructures for cancer theranostics.

Authors:  Jinping Wang; Beilu Zhang; Jingyu Sun; Wei Hu; Hongjun Wang
Journal:  Nano Today       Date:  2021-04-08       Impact factor: 18.962

Review 2.  Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies.

Authors:  Luman Liu; Prakash G Kshirsagar; Shailendra K Gautam; Mansi Gulati; Emad I Wafa; John C Christiansen; Brianna M White; Surya K Mallapragada; Michael J Wannemuehler; Sushil Kumar; Joyce C Solheim; Surinder K Batra; Aliasger K Salem; Balaji Narasimhan; Maneesh Jain
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.